Impax Asset Management Group’s West Pharmaceutical WST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-4,116
| Closed | -$1.35M | – | 327 |
|
2024
Q4 | $1.35M | Buy |
4,116
+1,049
| +34% | +$344K | 0.01% | 258 |
|
2024
Q3 | $921K | Buy |
3,067
+1,102
| +56% | +$331K | ﹤0.01% | 287 |
|
2024
Q2 | $647K | Hold |
1,965
| – | – | ﹤0.01% | 302 |
|
2024
Q1 | $778K | Hold |
1,965
| – | – | ﹤0.01% | 290 |
|
2023
Q4 | $692K | Buy |
1,965
+800
| +69% | +$282K | ﹤0.01% | 318 |
|
2023
Q3 | $437K | Sell |
1,165
-21
| -2% | -$7.88K | ﹤0.01% | 351 |
|
2023
Q2 | $454K | Hold |
1,186
| – | – | ﹤0.01% | 349 |
|
2023
Q1 | $411K | Sell |
1,186
-10,723
| -90% | -$3.72M | ﹤0.01% | 359 |
|
2022
Q4 | $2.8M | Sell |
11,909
-468
| -4% | -$110K | 0.01% | 212 |
|
2022
Q3 | $3.05M | Buy |
12,377
+1,688
| +16% | +$415K | 0.02% | 211 |
|
2022
Q2 | $3.23M | Hold |
10,689
| – | – | 0.02% | 210 |
|
2022
Q1 | $4.39M | Sell |
10,689
-55
| -0.5% | -$22.6K | 0.02% | 202 |
|
2021
Q4 | $5.04M | Sell |
10,744
-293
| -3% | -$137K | 0.02% | 196 |
|
2021
Q3 | $4.69M | Buy |
11,037
+6,600
| +149% | +$2.8M | 0.02% | 204 |
|
2021
Q2 | $1.59M | Hold |
4,437
| – | – | 0.01% | 259 |
|
2021
Q1 | $1.25M | Buy |
+4,437
| New | +$1.25M | 0.01% | 270 |
|